Table 2 Correlation between chemoresponse and expression of S100A6 in invasive breast cancer
From: S100A6 inhibits MDM2 to suppress breast cancer growth and enhance sensitivity to chemotherapy
Subtypes | n | pCR rate (S100A6 high/low) | P value |
|---|---|---|---|
All patients | 107 | 41.8%/11.5% |  < 0.0001 |
Luminal (non-HER2 +) | 57 | 17.9%/3.4% | 0.102 |
HER2 +  | 23 | 69.2%/20% | 0.036 |
TNBC | 27 | 64.3%/23.1% | 0.031 |